FDA Delays Cadence Drug Review: BioBuzz
IV Acetaminophen review pushed back to February 2010.
08:24AM 11/13/09
Glaxo, XenoPort Drug To Get Longer FDA Review
GlaxoSmithKline, XenoPort drug candidate gets extended FDA regulatory review
04:37PM 11/10/09
Doc Offers Top Hep C Drug Picks: BioBuzz
Vertex, InterMune, Pharmasset get positive reviews after recent Hep C meeting.
01:54PM 11/09/09
Xoma Waffles on Timing of Drug Partnership: BioBuzz
An expected deal for its diabetes drug may not happen until next year.
10:23AM 11/09/09
FDA Extends Review Of XenoPort-Glaxo Pain Drug
XenoPort and Glaxo says FDA review of neuropathic pain drug extended 3 months, to Feb. 2010
08:39AM 11/09/09
Ariad Upgraded, Xenoport Drug Delayed: BioBuzz
Analysts sees upside in two Ariad drugs while FDA delays decision on Xenoport drug.
07:51AM 11/09/09
Biotech Calendar: Key Dates for November
Your quick-and-dirty guide to key dates and events for biotech investors during November.
07:12AM 11/02/09
Depomed Says Shingles Pain Drug Meets Study Goal
Depomed says its post-shingles pain drug succeeded it trial, and shares hit three-year high
10:49AM 10/05/09
XenoPort Shares Dip On Diabetic Drug Study Failure
XenoPort shares fall as diabetic pain drug fails to meet goal in midstage clinical trial
11:39AM 04/27/09
XenoPort, Glaxo Pain Drug Fails In Midstage Study
XenoPort, GlaxoSmithKline pain drug fails to meet treatment goal in midstage clinical trial
09:06AM 04/27/09
XenoPort Says FDA Accepts New Solzira Application
XenoPort and Glaxo say FDA accepts new application for Solzira; XenoPort will be paid $23M
10:27AM 03/16/09



Connect with TheStreet